Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 20 November, 2025
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 519003 | NSE: MODINATUR

Modi Naturals Ltd: Intrinsic Value & Share Price Analysis

Current Price & Key Metrics −

Last Updated: November 20, 2025, 12:44 am

Market Cap 578 Cr.
Current Price 441
High / Low 667/320
Stock P/E15.8
Book Value 109
Dividend Yield0.00 %
ROCE18.7 %
ROE29.2 %
Face Value 10.0
PEG Ratio0.52

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Modi Naturals Ltd

Competitors of Modi Naturals Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Modi Naturals Ltd 578 Cr. 441 667/32015.8 1090.00 %18.7 %29.2 % 10.0
Pioneer Agro Extracts Ltd 9.86 Cr. 22.8 22.8/15.4329 12.10.00 %1.72 %1.53 % 10.0
NK Industries Ltd (NKIND) 40.2 Cr. 66.9 98.4/48.2 5840.00 %%% 10.0
Agro Tech Foods Ltd 2,969 Cr. 786 1,152/644432 2020.38 %2.69 %1.73 % 10.0
Industry Average1,773.50 Cr329.18258.93226.780.10%7.70%10.82%10.00

All Competitor Stocks of Modi Naturals Ltd

Latest Quarterly Results −

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 931141108492104120148147179190155147
Expenses 911131138190106114134133166174137132
Operating Profit 21-222-16131313161815
OPM % 2%1%-2%3%2%-1%5%9%9%7%8%11%10%
Other Income 0010000011001
Interest 1111123333322
Depreciation 0000022222222
Profit before tax 10-311-51999111312
Tax % 25%0%-13%16%16%-15%6%14%15%12%27%22%15%
Net Profit 10-211-4178881010
EPS in Rs 0.600.01-1.830.620.60-3.200.965.705.795.976.238.017.69

Last Updated: November 18, 2025, 11:33 am

Below is a detailed analysis of the quarterly data for Modi Naturals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Sales, as of Sep 2025, the value is 147.00 Cr.. The value appears to be declining and may need further review. It has decreased from 155.00 Cr. (Jun 2025) to 147.00 Cr., marking a decrease of 8.00 Cr..
  • For Expenses, as of Sep 2025, the value is 132.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 137.00 Cr. (Jun 2025) to 132.00 Cr., marking a decrease of 5.00 Cr..
  • For Operating Profit, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 3.00 Cr..
  • For OPM %, as of Sep 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Jun 2025) to 10.00%, marking a decrease of 1.00%.
  • For Other Income, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
  • For Interest, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
  • For Depreciation, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
  • For Profit before tax, as of Sep 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
  • For Tax %, as of Sep 2025, the value is 15.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Jun 2025) to 15.00%, marking a decrease of 7.00%.
  • For Net Profit, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 10.00 Cr..
  • For EPS in Rs, as of Sep 2025, the value is 7.69. The value appears to be declining and may need further review. It has decreased from 8.01 (Jun 2025) to 7.69, marking a decrease of 0.32.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss + Growth +

Last Updated: November 18, 2025, 11:33 am

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 443474418399663671
Expenses 430459412390607608
Operating Profit 1315595662
OPM % 3%3%1%2%8%9%
Other Income 412112
Interest 12471211
Depreciation 112488
Profit before tax 14132-23845
Tax % 25%28%42%-21%18%
Net Profit 1191-13137
EPS in Rs 8.317.400.85-1.0523.7027.90
Dividend Payout % 0%0%0%0%0%

Profit Loss Chart

YoY Net Profit Growth

Year2021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-18.18%-88.89%-200.00%3200.00%
Change in YoY Net Profit Growth (%)0.00%-70.71%-111.11%3400.00%

Modi Naturals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.

Last Updated: September 5, 2025, 3:51 pm

Balance Sheet & Cash Flow +

Balance Sheet Data Table

Last Updated: November 18, 2025, 11:33 am

MonthMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 131313131313
Reserves 55656977108129
Borrowings 2151142170149152
Other Liabilities 333738465959
Total Liabilities 121165263306330353
Fixed Assets 192627149145141
CWIP 009101654
Investments 000000
Other Assets 102139144157169158
Total Assets 121165263306330353

Below is a detailed analysis of the balance sheet data for Modi Naturals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
  • For Reserves, as of Sep 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2025) to 129.00 Cr., marking an increase of 21.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 152.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 149.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 3.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 59.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 59.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 353.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 4.00 Cr..
  • For CWIP, as of Sep 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 38.00 Cr..
  • For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 158.00 Cr., marking a decrease of 11.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 353.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..

However, the Borrowings (152.00 Cr.) are higher than the Reserves (129.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves & Borrowings Chart

Cash Flow - No data available for this post.

Free Cash Flow Table

MonthMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-8.00-36.00-137.00-161.00-93.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Key Ratios & Efficiency +

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 23.25-0.890.937.388.31
Diluted EPS (Rs.) 23.25-0.890.937.388.31
Cash EPS (Rs.) 29.192.132.078.529.40
Book Value[Excl.RevalReserv]/Share (Rs.) 91.3568.1064.5961.0053.62
Book Value[Incl.RevalReserv]/Share (Rs.) 91.3568.1064.5961.0053.62
Revenue From Operations / Share (Rs.) 498.19300.47330.24374.75349.78
PBDIT / Share (Rs.) 43.007.685.4912.7813.15
PBIT / Share (Rs.) 37.124.514.2611.6612.06
PBT / Share (Rs.) 28.33-1.301.4710.2311.04
Net Profit / Share (Rs.) 23.32-1.030.847.408.31
NP After MI And SOA / Share (Rs.) 23.32-1.030.847.408.31
PBDIT Margin (%) 8.632.551.663.413.75
PBIT Margin (%) 7.451.501.283.113.44
PBT Margin (%) 5.68-0.430.442.733.15
Net Profit Margin (%) 4.68-0.340.251.972.37
NP After MI And SOA Margin (%) 4.68-0.340.251.972.37
Return on Networth / Equity (%) 25.52-1.521.3012.1315.49
Return on Capital Employeed (%) 24.713.323.0917.9120.85
Return On Assets (%) 9.40-0.450.405.668.67
Long Term Debt / Equity (X) 0.580.941.070.000.00
Total Debt / Equity (X) 1.221.871.740.660.30
Asset Turnover Ratio (%) 2.081.411.953.310.00
Current Ratio (X) 1.221.241.531.592.06
Quick Ratio (X) 0.570.470.570.460.64
Inventory Turnover Ratio (X) 5.613.283.614.700.00
Interest Coverage Ratio (X) 4.891.321.978.9612.85
Interest Coverage Ratio (Post Tax) (X) 3.650.821.306.199.12
Enterprise Value (Cr.) 601.08422.48433.31295.48112.19
EV / Net Operating Revenue (X) 0.901.061.040.620.25
EV / EBITDA (X) 10.5141.3362.3718.266.74
MarketCap / Net Operating Revenue (X) 0.680.630.700.520.20
Price / BV (X) 3.752.813.613.231.36
Price / Net Operating Revenue (X) 0.680.630.700.520.20
EarningsYield 0.06-0.010.000.030.11

After reviewing the key financial ratios for Modi Naturals Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
  • For Cash EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 29.19, marking an increase of 27.06.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 498.19. It has increased from 300.47 (Mar 24) to 498.19, marking an increase of 197.72.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 43.00, marking an increase of 35.32.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 37.12. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 37.12, marking an increase of 32.61.
  • For PBT / Share (Rs.), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from -1.30 (Mar 24) to 28.33, marking an increase of 29.63.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
  • For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 8.63, marking an increase of 6.08.
  • For PBIT Margin (%), as of Mar 25, the value is 7.45. This value is below the healthy minimum of 10. It has increased from 1.50 (Mar 24) to 7.45, marking an increase of 5.95.
  • For PBT Margin (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 10. It has increased from -0.43 (Mar 24) to 5.68, marking an increase of 6.11.
  • For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 8. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from -1.52 (Mar 24) to 25.52, marking an increase of 27.04.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 24.71, marking an increase of 21.39.
  • For Return On Assets (%), as of Mar 25, the value is 9.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 9.40, marking an increase of 9.85.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.58, marking a decrease of 0.36.
  • For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.87 (Mar 24) to 1.22, marking a decrease of 0.65.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.41 (Mar 24) to 2.08, marking an increase of 0.67.
  • For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
  • For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.57, marking an increase of 0.10.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.61. This value is within the healthy range. It has increased from 3.28 (Mar 24) to 5.61, marking an increase of 2.33.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 4.89, marking an increase of 3.57.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.65. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 3.65, marking an increase of 2.83.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 601.08. It has increased from 422.48 (Mar 24) to 601.08, marking an increase of 178.60.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.90, marking a decrease of 0.16.
  • For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 41.33 (Mar 24) to 10.51, marking a decrease of 30.82.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
  • For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.75, marking an increase of 0.94.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
  • For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.06, marking an increase of 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Financial Efficiency Data Table

MonthMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days1715172526
Inventory Days72959812566
Days Payable812213322
Cash Conversion Cycle81989411770
Working Capital Days4234372614
ROCE %14%3%2%19%

ROCE/ROE % Chart

EPS Chart

Profitability Ratios Chart

Valuation Ratios Chart

Shareholding Pattern +

Shareholding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters67.50%67.50%67.50%67.50%69.09%69.09%69.09%69.09%69.09%69.09%69.09%69.09%
DIIs1.73%1.73%1.73%1.73%0.06%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public30.76%30.78%30.77%30.78%30.85%30.91%30.91%30.90%30.91%30.91%30.92%30.90%
No. of Shareholders6,2686,2055,8616,1356,4646,3386,3046,1026,7086,5586,5046,634

Shareholding Pattern Chart

No. of Shareholders Chart

Modi Naturals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

Fair Value, Analysis & About Company +

Fair Value

Fair Value of Modi Naturals Ltd as of November 20, 2025 is: 410.35

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 20, 2025, Modi Naturals Ltd is Overvalued by 6.95% compared to the current share price 441.00

Intrinsic Value of Modi Naturals Ltd as of November 20, 2025 is: 535.09

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 20, 2025, Modi Naturals Ltd is Undervalued by 21.34% compared to the current share price 441.00

Last 5 Year EPS CAGR: 30.40%

*Investments are subject to market risks

StrengthWeakness
  1. The company has shown consistent growth in sales (511.33 cr) and profit (18.33 cr) over the years.
  1. The stock has a low average ROCE of 7.60%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 30.60, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 92.00, which may not be favorable.
  4. The company has higher borrowings (114.17) compared to reserves (83.83), which may suggest financial risk.

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Modi Naturals Ltd:
    1. Net Profit Margin: 4.68%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 24.71% (Industry Average ROCE: 7.7%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 25.52% (Industry Average ROE: 10.82%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 3.65
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.57
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 15.8 (Industry average Stock P/E: 258.93)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 1.22
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Modi Naturals Ltd. is a Public Limited Listed company incorporated on 06/07/1974 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L15142DL1974PLC007349 and registration number is 007349. Currently Company is involved in the business activities of Manufacture of vegetable oils and fats excluding corn oil. Company's Total Operating Revenue is Rs. 338.01 Cr. and Equity Capital is Rs. 13.31 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Edible Oils & Solvent Extraction405, Deepali Building, 92, Nehru Place, New Delhi Delhi 110019investors@modinaturals.com
http://www.modinaturals.com
Management
NamePosition Held
Mr. Anil ModiChairman & Managing Director
Mr. Akshay ModiJoint Managing Director
Mrs. Aditi ModiWhole Time Director
Mr. Ankit GargIndependent Director
Mrs. Ankita SingalIndependent Director
Mr. Udit JainIndependent Director

FAQ

What is the intrinsic value of Modi Naturals Ltd?

Modi Naturals Ltd's intrinsic value (as of 19 November 2025) is 410.35 which is 6.95% lower the current market price of 441.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 578 Cr. market cap, FY2025-2026 high/low of 667/320, reserves of ₹129 Cr, and liabilities of 353 Cr.

What is the Market Cap of Modi Naturals Ltd?

The Market Cap of Modi Naturals Ltd is 578 Cr..

What is the current Stock Price of Modi Naturals Ltd as on 19 November 2025?

The current stock price of Modi Naturals Ltd as on 19 November 2025 is 441.

What is the High / Low of Modi Naturals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Modi Naturals Ltd stocks is 667/320.

What is the Stock P/E of Modi Naturals Ltd?

The Stock P/E of Modi Naturals Ltd is 15.8.

What is the Book Value of Modi Naturals Ltd?

The Book Value of Modi Naturals Ltd is 109.

What is the Dividend Yield of Modi Naturals Ltd?

The Dividend Yield of Modi Naturals Ltd is 0.00 %.

What is the ROCE of Modi Naturals Ltd?

The ROCE of Modi Naturals Ltd is 18.7 %.

What is the ROE of Modi Naturals Ltd?

The ROE of Modi Naturals Ltd is 29.2 %.

What is the Face Value of Modi Naturals Ltd?

The Face Value of Modi Naturals Ltd is 10.0.

document.querySelectorAll(‘details’).forEach(d => { const span = d.querySelector(‘summary span’); const content = d.querySelector(‘div’); // Initial state content.style.overflow = ‘hidden’; content.style.transition = ‘all 0.4s ease’; d.addEventListener(‘toggle’, () => { span.textContent = d.open ? ‘−’ : ‘+’; span.style.transform = d.open ? ‘rotate(0)’ : ‘rotate(90deg)’; if (d.open) { content.style.maxHeight = content.scrollHeight + 60 + ‘px’; content.style.opacity = ‘1’; content.style.paddingTop = ’20px’; content.style.paddingBottom = ’20px’; } else { content.style.maxHeight = ‘0’; content.style.opacity = ‘0’; content.style.paddingTop = ‘0’; content.style.paddingBottom = ‘0’; } }); // Trigger once on load for open sections if (d.open) { span.textContent = ‘−’; content.style.maxHeight = content.scrollHeight + 60 + ‘px’; content.style.opacity = ‘1’; content.style.padding = ’20px’; } });
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Modi Naturals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore More Stocks